Trial NCT00960063

View at ClinicalTrials.gov 
Org. Study IDs: P05883
Secondary IDs: MK-7454-006

Last trial update was posted on 2018-08-27

MeSH Interventions

Cyclophosphamide Doxorubicin Etoposide Ifosfamide Irinotecan Temozolomide Vincristine

MeSH Conditions

Bone Neoplasms Kidney Neoplasms Neoplasms Neuroblastoma

Other Conditions

Bone Cancer Kidney Tumor Solid Tumors

Stopping Reasons

Study was terminated for business reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID